Cargando…
Adding recombinant AAVs to the cancer therapeutics mix
Gene therapy is a powerful biological tool that is reshaping therapeutic landscapes for several diseases. Researchers are using both non-viral and viral-based gene therapy methods with success in the lab and the clinic. In the cancer biology field, gene therapies are expanding treatment options and...
Autores principales: | Mulcrone, Patrick L., Herzog, Roland W., Xiao, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588955/ https://www.ncbi.nlm.nih.gov/pubmed/36321134 http://dx.doi.org/10.1016/j.omto.2022.09.009 |
Ejemplares similares
-
Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism
por: Mulcrone, Patrick L., et al.
Publicado: (2023) -
Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
por: Lam, Anh K., et al.
Publicado: (2022) -
Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
por: Zhang, Junping, et al.
Publicado: (2022) -
Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice
por: Mulcrone, Patrick L., et al.
Publicado: (2022) -
AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009)